News & Perspective

Nov 07, 2006

Nov 07, 2006

Federal workers abroad urged to store food, water

Editor's note: Shortly after publication of this story, the US Consulate in Hong Kong first changed and later removed its Web page advising employees to stockpile a 12-week supply of food and water.

(CIDRAP News) – The US State Department is advising government employees overseas to stockpile enough food and water to last up to 12 weeks in preparation for the threat of a severe influenza pandemic.

Nov 03, 2006

Nov 03, 2006

Study says new H5N1 strain pervades southern China

(CIDRAP News) – A new subtype of H5N1 avian influenza virus has become predominant in southern China over the past year, possibly through its resistance to vaccines used in poultry, and has been found in human H5N1 cases in China, according to researchers from Hong Kong and the United States.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Oct 13, 2006

Oct 13, 2006

CDC seeks data on nondrug prevention of pandemic flu

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) plans to fund eight studies on whether simple measures such as handwashing, "cough etiquette," and face masks could help limit the extent of the next influenza pandemic.

The CDC announced this week it would provide a total of $5.2 million to research institutions, some outside the United States, to assess nonpharmaceutical measures for battling pandemic flu.

Oct 13, 2006

Study supports concept of 2-stage H5N1 vaccination

(CIDRAP News) – The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Sep 13, 2006

Sep 13, 2006

Live H5N1 vaccines show potential in animal study

(CIDRAP News) – Live-virus vaccines made from a combination of H5N1 avian influenza virus and another flu strain protected laboratory mice and ferrets from deadly infection with several different H5N1 strains, according to a report published yesterday.

Jul 31, 2006

Jul 31, 2006

Hybrid avian-human flu virus didn't spread in lab study

(CIDRAP News) – In an experiment designed to mimic events that could launch an influenza pandemic, a synthetic influenza virus made by combining an H5N1 avian flu virus with a human flu virus turned out to be no more contagious in an animal model than the natural H5N1 virus, US scientists are reporting this week.

Mar 06, 2006

Mar 06, 2006

Chinese man had H5N1; WHO hones pandemic plans

(CIDRAP News) – As the H5N1 avian influenza virus continued to claim human victims, World Health Organization (WHO) and other experts met in Geneva today for a 3-day conference to hone the agency's pandemic response plan.

Mar 03, 2006

Mar 03, 2006

WHO sets meeting on flu pandemic containment

(CIDRAP News) – Public health experts will meet in Geneva next week to continue developing the World Health Organization's (WHO's) draft plan for quick action to head off a potential influenza pandemic.

The WHO announced the meeting as a Hong Kong official reported another possible human case of H5N1 avian flu in China, involving a 32-year-old man who died yesterday.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»